Signal Peptide
Signal Peptide
Signal Peptide
This article is a revision of the previous edition article by PS Lovett, volume 2, pp 1078–1079, © 2001, Elsevier Inc.
The messenger RNA (mRNA) region that precedes the coding entering the structural genes of an operon. Transcription ter
sequence for a gene is called the ‘leader sequence’. This region mination is relieved when the intracellular concentration of
is also known as the ‘five prime untranslated region (5′ UTR)’ the end-product amino acid of the operon-specified enzymes
(Figure 1). It begins at the +1 position (where transcription falls below some minimal level. The level of the end-product
starts) and ends one nucleotide before the start codon of the amino acid is sensed by the translation of a short
coding region. Leader sequences have the propensity for form leader-encoded open reading frame (ORF) immediately
ing secondary structures (stem-loops) by base pairing of upstream of the transcription termination signal; the ORF
complementary sequences. In prokaryotes, the leader contains one or more codons for the operon end-product
sequences are usually short. In eukaryotes and viruses, the amino acid. Low intracellular levels of the end-product
leader sequences may vary from few nucleotides to several amino acid prevent high-level charging of the cognate transfer
hundred nucleotides. It usually contains the site for ribosome RNA (tRNA), resulting in ribosomal pausing at leader codons
binding. At times, the leader sequence may be translated into for the end-product amino acid. The paused ribosome inter
a short-leader peptide, which can affect the transcription of feres with the secondary structure of the transcription
the rest of the mRNA. terminator causing the formation of a second configuration
Leader sequences can regulate downstream expression at the in the mRNA, the attenuator, which allows transcription to
levels of transcription or translation in bacteria and can mod enter the downstream operon-coding sequence.
ulate downstream translation in eukaryotes. Leader sequences Transcription antitermination involves the formation of a
in viruses can play an important role in the regulation of gene transcription termination structure in leader mRNA, which is
expression, replication, and pathogenicity. Mutations in the either inhibited or facilitated by the interaction of a protein (or
leader sequences of cellular mRNAs can have implications for a tRNA molecule) with leader mRNA sequences. For example,
disease and tumorigenesis. the trp RNA-binding attenuation protein (TRAP) plus trypto
phan binds to the leader sequence of the Bacillus subtilis trp
operon causing the formation of a transcription terminator.
Transcription in Bacteria In the absence of tryptophan, TRAP fails to bind to the leader
sequence and an antiterminator structure forms allowing tran
Transcription attenuation comprises one level of regulation scription to enter the operon. Other operons that follow this
for many amino acid biosynthetic operons in enteric bacteria. general pattern of regulation include the bgl operon of
Nucleotide sequences within the leader cause the formation Escherichia coli, the pur, pyr, hut, lic, and glp operons and the
of a domain of secondary structure which acts as a tran sac regulon of B. subtilis, the ami operon of Pseudomonas, and the
scription termination signal for bacterial RNA polymerase. nas regulon of Klebsiella. Aminoacyl-tRNA synthetases in
Transcription initiated in the upstream promoter terminates Gram-positive bacteria are also regulated by antitermination.
within the leader so as to prevent RNA polymerase from The uncharged tRNA interacts with the leader sequences to
Poly-A
Cap 5′UTR Coding sequence 3′UTR
Start Stop tail
5′ 3′
Figure 1 The structure of a typical human protein-coding mRNA, including the untranslated regions (UTRs).
promote the formation of an antiterminator structure allowing structure or decreased recognition of IRPs, leading to human
transcription to enter the tRNA synthetase-coding sequence. disease.
2. Structured 5′ UTRs and translation inhibition. Around
10% of all mRNAs contain unusually long 5′ UTRs. Many of
Translation in Bacteria those mRNAs encode proto-oncogenes or genes whose protein
products are implicated in cell growth. These long 5′ UTRs give
Translation attenuation regulates several antibiotic-inducible, the propensity for formation of stable secondary structure that
antibiotic-resistance genes (e.g., cat, erm). A domain of second may inhibit translation initiation by blocking the progress of
ary structure in leader mRNA sequesters the ribosome-binding the scanning ribosome. These structured mRNAs are particu
site for the downstream resistance determinant, preventing larly dependent on the activity of the cap-dependent
translation initiation. Antibiotic-induced ribosome stalling in unwinding machinery for their translation. Since many of
a short ORF within the leader causes destabilization of the these structured RNAs are associated with growth control,
secondary structure, which frees the ribosome-binding site mutation in the 5′ UTR of these mRNAs can cause overexpres
allowing translation of a coding sequence whose protein pro sion of the protein product leading to tumor genesis.
duct can neutralize the antibiotic. 3. Internal ribosome entry site (IRES). Certain eukaryotic
Translational repression is well exemplified by certain oper mRNAs contain an internal ribosome entry site (IRES) prior
ons encoding bacterial ribosomal proteins. The translational to the coding sequence. An IRES presumably functions in an
repressor is a single ribosomal protein encoded by the operon; analogous manner to a bacterial ribosome-binding site in
the nonregulatory function of this protein is to act as a struc allowing translation initiation by directly serving as a
tural component of the ribosome. In several examples, the ribosome-binding target. The presence of an IRES preceding a
binding target for the repressor protein in the operon leader coding sequence in a eukaryotic mRNA enables an mRNA that
sequence mimics the structure or sequence of the ribosomal is not capped to be translated.
RNA (rRNA) target for the same protein. Binding of the regu IRESs are responsible for translation of many viral and
latory protein to leader mRNA is presumably of lower affinity cellular mRNAs with clinical relevance in humans. Mutations
than that for rRNA binding in vivo. Leader binding by the in the region of the IRES have been found to influence the
repressor interferes with translation of operon mRNA by translational efficiency of the mRNA.
occluding the ribosome-binding site or by changing the sec
ondary structure of leader.